Home | Welcome to Contract Pharma   
Last Updated Saturday, May 30 2015


Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published March 18, 2013
Adds expertise in neurology, biologics and clinical research Read More »
Published March 18, 2013
To provide integrated service offerings Read More »
Published March 18, 2013
Will sell and distribute Abstral in the U.S. Read More »
Published March 14, 2013
Seeks maker for preclinical studies of breast cancer drug Read More »
Fill-Finish Innovation
By Ronald A. Rader and Eric S. Langer, BioPlan Associates, Inc.
Published March 13, 2013
Showing Sparks of Life Read More »
Published March 12, 2013
Taylor brings 25 years of experience in life sciences Read More »
Published March 11, 2013
Gains access to advanced facilities and instrumentation Read More »
Packaging Equipment & Trends
By Kristin Brooks, Contract Pharma
Published March 6, 2013
Heightened capabilities provide increased flexibility Read More »
Published March 6, 2013
What are the common biocompatibility tests that drug companies must perform during new drug development? Read More »
By Derek B. Lowe, Contributing Editor
Published March 6, 2013
What happens when money stands still? Read More »
By Michael A. Martorelli, Contributing Editor
Published March 6, 2013
Watch out for some mischief Read More »
By Gil Roth, Contract Pharma
Published March 6, 2013
Plus: Insurgents and hospital bills Read More »
CRO Strategic Partnerships
By Josh Schultz, PAREXEL
Published March 6, 2013
Benefits for small- and mid-sized biopharma Read More »
Implementing Process Validation Guidances
By Peter H. Calcott, Ph.D., President, Calcott Consulting LLC
Published March 6, 2013
Complying with FDA and EU for small and mid-sized companies Read More »
Published March 4, 2013
Revenues up 18% in the quarter Read More »
Published March 1, 2013
Baxter acquires facility, land, and equipment in Brooklyn Park, MN Read More »
Published February 26, 2013
Baxter International Inc.'s BioPharma Solutions business has begun an approximately 1,750 square meter capacity expansion at the company's fill/finish cytotoxic contract manufacturing facility in Halle (Westfalen), Germany. The facilit… Read More »
Published February 26, 2013
Aims to match patients for biomarker oncology trials Read More »
Published February 22, 2013
Aims to advance an immune therapeutic treatment Read More »
Published February 21, 2013
We Understand Parenterals As a parenterals specialist, BioPharma Solutions offers unique delivery systems and a variety of manufacturing solutions to meet complex and traditional sterile manufacturing challenges Experience makes the difference. We u… Read More »
Published February 21, 2013
BioPharma Solutions’ Bloomington, Indiana, USA facility is home to scientists with expertise in parenteral product formulation, process and analytical development.… Read More »
Published February 21, 2013
BioPharma Solutions’ facility in Bloomington, Indiana, USA, is one of the largest contract manufacturers of sterile products in North America, with a state-of-the-art 600,000 square foot campus.… Read More »
Published February 20, 2013
Hudson brings 20 years of experience Read More »
Published February 19, 2013
Adds commercial and clinical filling lines Read More »
Published February 13, 2013
Will combine immune therapy with Albufuse technology Read More »
Published February 12, 2013
BMS to market several OTC medicines in Latin America Read More »
Published February 11, 2013
To provide solutions aimed at overcoming development challenges Read More »
Published February 5, 2013
Burch, Mohan, and Solinger expand therapeutic expertise Read More »
Published February 4, 2013
Expands FSP division and medical and safety services Read More »
Published February 1, 2013
PAI triggered by a top pharma company’s NDA filing Read More »
By Gil Roth
Published January 28, 2013
Will explore hydroponic system in biopharma protein system Read More »
Published January 25, 2013
Recognized by green building program Read More »
Published January 23, 2013
Combines rAlbumin line under Recombumin name Read More »
Published January 22, 2013
Adds capabilities and instrumentation Read More »
Published January 22, 2013
What are the top concerns when choosing a clinical trial site in developed or emerging markets, and do cheaper prices in emerging markets outweigh those concerns? Read More »
Newsmakers: Guido Driesen
By Gil Y. Roth, Contract Pharma
Published January 22, 2013
Guido Driesen on leading Capsugel after the Pfizer spinoff Read More »
Published January 2, 2013
Resumes Abbott’s research-based business Read More »
Published December 19, 2012
Products will be sold under a co-branding arrangement Read More »
Published December 18, 2012
To market Umetrics chemometrics software Read More »
Published December 10, 2012
Ryan to lead regulatory consulting and submissions offerings Read More »
Published December 6, 2012
Launches Strategic Advisory Unit Read More »
Published December 5, 2012
Sarno responsible for Pfēnex Technology partners Read More »
Published December 4, 2012
To market breast cancer drug NeuVax in Israel Read More »
Published November 30, 2012
KESA Partners expands pharma outsourcing business Read More »
Published November 27, 2012
Aims to drive greater efficiency for sponsors in the Asia-Pac region Read More »
Published November 9, 2012
To aid small and virtual biopharma and device companies Read More »
Published October 30, 2012
Acquires stake in Vital River Read More »
Published October 24, 2012
Will provide process development, manufacture at Australian Facility Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On